Libella Gene Therapeutics A biotechnology initiative, Genetics, says that the genetic therapy that she is currently developing could slow down aging. For $ 1 million, the company will offer its elderly clients an experimental treatment that will allow them to expand their telomeres, which are some of the things that are on our chromosomes, such as protective caps, but which are becoming more and more in closer with age.
Libella uses technology to transfer a gene specific to patients' cells during telomere reconstruction. The company predicts that aging customers will slow down or even make them younger. Libella, to increase the length of telomere molecules to transport the molecules needed to inject the patient suggests. Libella CEO Jeff Mathissays he knows what he's trying to do looks like science fiction but believes that it's a scientific reality. However, experts in the field are not convinced that what the company does is commercial.
Leigh Turner, Biology Specialist at the University of MinnesotaAlthough Libella Gene Therapeutics is based in the United States, they have managed to find a way to escape US federal law, he said. Indeed, the work of the company takes place outside Zip USA, 40 kilometers north of Bogota, because the necessary permits are not available. Turner said the biotech company had carried out the anti-aging experience in no big hospital, but instead had chosen a low-budget clinic, which was annoying. Turner added that he thinks it's a job in which a lot of things can go wrong.
It is not known where Libella got the viruses needed for treatment. Virovek, a California-based company, is known as the maker of Libella, but Virovek refuses to answer questions. As a result, Libella promises something that can happen in sci-fi movies, but it is questionable of its reality.